Kirill Dmitriev, head of the Russian Direct Investment Fund, told Reuters that Russia expects WHO to approve the Sputnik-V vaccine against COVID-19 within two months.
The Russian fund is responsible for marketing the vaccine.
Dmitriev stated that the European Medicines Agency, which is also reviewing the Russian vaccine, “has obtained all the basic information available, and there are no important notes so far at all.”